The FHP™ is used to identify menstrual cycle deficits and imbalances in progesterone, estrogen, testosterone and DHEA/DHEA-S. This panel provides a profile of the hormone fluctuations in a woman's cycle for test-guided BHRT. The FHP™ test is most applicable in cycling women with any of the following conditions:

• Weight gain.
• Functional infertility.
• Osteoporosis.
• Endometriosis and ovarian cysts.
• Fibroids and fibrocystic breasts.
• Increased risk of breast cancer.
• Recurrent cycle-related symptoms and irregularities, such as PMS, migraines, breast tenderness, emotional and cognitive issues, insomnia and spotting. 

Literally, menopause means the cessation of the monthly menstrual cycle; it signals the end of a woman's natural childbearing years.

Menopause is neither a disease nor an illness-it is a natural and usually gradual change in glandular function. It has its origins in the beginning of menses and culminates in a series of hormonal changes that result in the cessation of menstrual flow. 

This transition produces a variety of bodily manifestations and symptoms, due to changes in the production of hormones and the timing of their release.

Various body parts undergo change and can produce one or more of the following symptoms:

• Bleeding irregularities
• Vaginal dryness
• Hot flashes or sweats
• Changes in sex drive

• Insomnia
• Nervousness or irritability
• Headaches
• Mood changes
• Depression

• Skin aging or cosmetic changes
• Osteoporosis
• Altered fat and carbohydrate metabolism
• Atherosclerosis